Correlation of clinical characteristics and immunologic profile of stage III NSCLC patients.

e20552Background: Recently, immunotherapy has significantly increased mPFS and mOS in unresectable stage III NSCLC whom completed concurrent chemoradiation (CCRT). Predictive biomarker for immunoth...